Neuroprotection in stroke by complement inhibition and immunoglobulin therapy
- 6 February 2009
- journal article
- review article
- Published by Elsevier BV in Neuroscience
- Vol. 158 (3), 1074-1089
- https://doi.org/10.1016/j.neuroscience.2008.07.015
Abstract
No abstract availableKeywords
This publication has 150 references indexed in Scilit:
- Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell deathProceedings of the National Academy of Sciences of the United States of America, 2007
- New perspectives on mannan-binding lectin-mediated complement activationImmunobiology, 2007
- Reduced Tissue Damage and Improved Recovery of Motor Function after Traumatic Brain Injury in Mice Deficient in Complement Component C4Journal of Cerebral Blood Flow & Metabolism, 2007
- Expression of complement regulators and receptors on human NT2-N neurons—Effect of hypoxia and reoxygenationMolecular Immunology, 2007
- The Role of the N-terminal Domain of the Complement Fragment Receptor C5L2 in Ligand BindingPublished by Elsevier BV ,2007
- The antiinflammatory activity of IgG: the intravenous IgG paradoxThe Journal of Experimental Medicine, 2007
- Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptorsProceedings of the National Academy of Sciences of the United States of America, 2006
- Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson’s diseaseBiochemical and Biophysical Research Communications, 2006
- The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal ratsNeuroscience Letters, 2005
- Antigen‐specific immunotherapy for autoimmune disease: fighting fire with fire?Immunology, 2001